Newsblaster Archived Run Click here to return to today's news. Friday, June 6, 2008 Articles from 06/03/2008 to 06/06/2008 Last update: 4:30 AM EST
Search for: Offline summarization (match summaries) Hybrid summarization Online summarization Offline summarization (match articles) U.S. World Finance Sci/Tech Entertainment Sports View Today's Images Back to Archive Index About Newsblaster About today's run Newsblaster in Press Academic Papers Article Sources: seattletimes. nwsource.com (142 articles) washingtonpost.com (142 articles) news.bbc.co.uk (138 articles) nytimes.com (128 articles) latimes.com (128 articles) boston.com (125 articles) baltimoresun.com (97 articles) dallasnews.com (83 articles) suntimes.com (77 articles) sfgate.com (75 articles) abcnews.go.com (68 articles) cbc.ca (49 articles) nypost.com (28 articles) timesonline.co.uk (26 articles) foxnews.com (24 articles) ft.com (21 articles) sportsillustrated. cnn.com (12 articles) cbsnews.com (12 articles) cnn.com (11 articles) money.cnn.com (8 articles) latimesblogs. latimes.com (6 articles) wired.com (5 articles) usatoday.com (3 articles) health.nytimes.com (2 articles) swamppolitics.com (2 articles) haaretz.com (2 articles) blog.wired.com (2 articles)	F.D.A. Reviews Arthritis Drugs for Links to Cancer Summary from multiple countries, from articles in English The Food and Drug Administration said Wednesday that it was investigating whether four drugs used to treat rheumatoid arthritis and other immune system diseases might increase the risk of cancer in children. (article 4) Amgen's multibillion-dollar anemia drug Aranesp is facing further safety concerns after a medical newsletter reported that a Danish study of the drug in head and neck cancer was halted as a result of adverse outcomes in patients taking part. (article 1) The development was reported in The Cancer Letter, which said the study was temporarily halted in October after an interim analysis of the first 484 patients turned up a statistically significant increase in disease recurrence. (article 1) The FDA began investigating cancer cases linked to the class of medicines, known as TNF blockers, which also includes Abbott Laboratories' Humira, 10 years ago. (article 5) " While the review is ongoing, FDA advises prescribers to weigh the possible association with lymphoma and other cancers against the benefits of treatment when prescribing TNF blockers to children and young adults the agency said. (article 5) WASHINGTON - Federal regulators are investigating whether a group of best-selling arthritis drugs made by Abbott Laboratories, Schering-Plough Corp. and other companies heighten the risk of cancer in youngsters. (article 2) Other summaries about this story: Summary from United States, from articles in English (5 articles) [compare] Other stories about cancer, patients and children: Pediatric cancer most common in N.E., study shows - (5 articles) Event tracking: Track this story's development in time Story keywords cancer, patients, children, immune, study Source articles NY Times Health Information (health.nytimes.com, 06/05/2008, 186 words) FDA reviewing arthritis drugs for cancer link (seattletimes.nwsource.com, 06/04/2008, 381 words) Abbott drug investigated for link to juvenile cancer :: CHICAGO SUN-TIMES :: Business (suntimes.com, 06/04/2008, 236 words) F.D.A. Reviews Arthritis Drugs for Links to Cancer (nytimes.com, 06/05/2008, 764 words) Drugs' risk of cancer under US scrutiny (boston.com, 06/05/2008, 310 words) Rheumatoid arthritis drug may increase cancer risk (cbc.ca, 06/04/2008, 394 words) blaster@cs.columbia.edu